FDA Approved: SAPHNELO — Original Application (AstraZeneca Pharmaceuticals LP)

View source ↗

Summary

FDA approved SAPHNELO (anifrolumab-fnia) from AstraZeneca in its original application for adults with moderate to severe systemic lupus erythematosus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• SAPHNELO (ANIFROLUMAB-FNIA)

Snippet

ORIG AP for SAPHNELO (ANIFROLUMAB-FNIA)